NMD4C at Ottawa NMD 2023

This September 7th to 9th the University of Ottawa Éric Poulin Centre for Neuromuscular Disease (CNMD) hosted the 6th Ottawa International Conference on Neuromuscular Disease and Biology (Ottawa NMD 2023), with a program emphasizing recent breakthroughs in basic and translational research and clinical discoveries in neuromuscular disease. As a network, we had the opportunity to present three posters on the outcomes of select network activities from the first NMD4C grant period. Read the NMD4C abstracts here. All of the Ottawa NMD abstracts are also available on the event website. We also hosted a booth at the conference to share information on the network, recruit new members, and discuss our work with the many investigators and neuromuscular stakeholders who visited! 

NMD4C Posters at Ottawa NMD 2023 

  • Compliance to Duchenne Muscular Dystrophy Care Considerations in Canada  
  • Expert Patient Capacity Building in Neuromuscular Disease Research   
  • The Neuromuscular Disease Network for Canada (NMD4C): An interdisciplinary national collaboration to tackle unmet needs for NMD research and care

Read the NMD4C abstracts here.

NMD4C Investigators that Presented at Ottawa NMD 2023 

The three-day Ottawa NMD 2023 conference hosted nationally and internationally renowned basic researchers and clinicians to present talks highlighting advances in all aspects of NMD research, including new clinical diagnostic techniques, biology of disease pathogenesis, basic muscle and stem cell biology, and promising therapies to treat NMDs. Several network investigators delivered talks across the action-packed three-day program. 

  • Dr Craig Campbell: Duchenne Muscular Dystrophy Episignature 
  • Dr Natasha Chang: Muscle stem cell dysfunction in Duchenne muscular dystrophy 
  • Dr Gerald Pfeffer: Transcriptomic profiles and pathologic correlation in adult-onset myopathies 
  • Dr Hernan Gonorazky: MRI in the age of Artificial Intelligence 
  • Dr Mireille Khacho: Impact of Mitochondrial Dynamics on Muscle Stem Cell Function: Insights from Physiology, Diseases and Ageing 
  • Dr Hanns Lochmüller: Congenital myasthenic syndromes – diagnosis and therapy 
  • Dr Rami Massie: Update in autoimmune neuropathies 
  • Dr Hugh McMillan: Gene therapy in spinal muscular atrophy 
  • Dr Kerri Schellenberg: Clinical Updates in Spinal Bulbar Muscular Atrophy 
  • Dr Jodi Warman Chardon: Muscle Imaging in Genetic and Autoimmune Muscle Diseases 
  • Dr Nicolas Dumont: Clearance of defective muscle stem cells by senolytics reduces the expression of senescence associated secretory phenotype and restores myogenesis in myotonic dystrophy type 1 
  • Stacey Lintern / Dr Homira Osman: Opening remarks at Keynote Session 

We are looking forward to Ottawa NMD 2025!

NMD4C at Ottawa NMD 2023, parliament building in Ottawa in the background.

Read next...

2027 NMD4C-MDC Clinical Neuromuscular Fellowship Competition

Sixth Annual NMD4C and MDC Clinical Fellowship Competition from Opens May 1st

Together, NMD4C and MDC are excited to open our 2027 annual funding competition to provide clinical fellowship award(s) in neuromuscular medicine and electromyography (EMG)!  This annual funding competition provides one-year salary support ($80,000) for early-career clinicians to participate in Canadian neuromuscular medicine and EMG fellowship training programs.

04-2026 - Advancing Neuromuscular Research_ MDC Awards $700k to Seven NMD4C Investigator-Led Projects

Advancing Neuromuscular Research: MDC Awards $700k to Seven NMD4C Investigator-Led Projects

We’re proud to share that neuromuscular research led by our NMD4C Investigators and Leads; Dr. Hanns Lochmüller, Dr. Rashmi Kothary, Dr. Rami Massie, Dr. Elise Duchesne, Dr. Omid Kiamanesh, and Dr. Nicolas Dumont,  have been recognized in Muscular Dystrophy Canada’s 2026 Neuromuscular Clinical and Translational Research Grant announcement. Drawing from MDC’s national funding update, we’re…

2026 NMD4C Awards Recipients

Announcing the 2026 NMD4C Award Recipients

We are excited to announce the recipients of the 2026 NMD4C Awards, recognizing excellence, leadership, and impact across Canada’s neuromuscular research community. In this fourth cycle, the program introduces two new award categories, and expand on our ability to celebrate the work of contributions of trainees and patient partners who strengthen our national network.